SARS-CoV-2 and Atherosclerosis: Should COVID-19 Be Recognized as a New Predisposing Cardiovascular Risk Factor?

At the beginning of the COVID-19 pandemic, the lung was recognized as the main target organ; now, new evidence suggests that SARS-CoV-2 infection leads to vascular disease. In a previous review, we supposed a bidirectional link between endothelial dysfunction and COVID-19, identifying atherosclerosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinciguerra, Mattia, Romiti, Silvia, Sangiorgi, Giuseppe Massimo, Rose, David, Miraldi, Fabio, Greco, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539652/
https://www.ncbi.nlm.nih.gov/pubmed/34677199
http://dx.doi.org/10.3390/jcdd8100130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539652/
https://www.ncbi.nlm.nih.gov/pubmed/34677199
http://dx.doi.org/10.3390/jcdd8100130

Ejemplares similares